Your search returned 3 results.

Results
	1.	A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions. [electronic resource] by Leibowitz, Mark T Zamora, Cynthia A Brzeczko, Albert W Stark, Jeffrey G Producer: 20141106 In: American journal of therapeutics vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers. [electronic resource] by Bass, Almasa Stark, Jeffrey G Pixton, Glenn C Sommerville, Kenneth W Zamora, Cynthia A Leibowitz, Mark Rolleri, Robert Producer: 20121221 In: Clinical therapeutics vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs. [electronic resource] by Nomoto, Maiko Zamora, Cynthia A Schuck, Edgar Boyd, Peter Chang, Min-Kun Aluri, Jagadeesh Siu, Y Amy Lai, W George Yasuda, Sanae Ferry, Jim Rege, Bhaskar Producer: 20190624 In: British journal of clinical pharmacology vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)